#Alzheimersdisease

Recent research has uncovered a significant connection between low vitamin D levels and a higher risk of developing Alzheimer’s disease. This landmark study, drawing on data from a 2023 meta-analysis published in a reputable scientific journal, has highlighted that individuals with vitamin D serum levels below 25 ng/mL have a 59% increased risk of Alzheimer’s than those with higher levels. This finding brings new insight into preventive strategies for Alzheimer’s, a disease that affects millions worldwide and poses an increasing concern across Thailand.

A new analysis highlights a link between low vitamin D levels and higher Alzheimer’s risk. The study draws on a 2023 meta-analysis and shows that individuals with vitamin D serum levels below 25 ng/mL have a markedly greater risk of developing Alzheimer’s than those with higher levels. The findings offer promising directions for prevention in Thailand, where dementia is an increasing public health concern amid aging populations.

Alzheimer’s disease remains the leading cause of dementia worldwide, accounting for a substantial share of cases. As populations age, identifying modifiable risk factors becomes even more critical. Vitamin D is gaining attention for brain health due to its receptors throughout the brain and its role in cognitive function. Ensuring adequate levels may support long-term brain health and could complement other preventive measures.

A recent study in the Journal of Clinical Sleep Medicine explores how specific sleep patterns relate to brain health and early signs of Alzheimer’s disease. Researchers followed 270 participants, using polysomnography and brain imaging to examine sleep stages and brain volume changes. The results indicate that reductions in slow-wave sleep and REM sleep correlate with brain regions commonly affected early in Alzheimer’s, suggesting sleep quality could be a modifiable risk factor.

A new study suggests vitamin D supplementation may cut dementia risk, offering a potential addition to Thailand’s cognitive health strategy. The research tracked nearly 12,500 older adults who were dementia-free at baseline and found that those taking vitamin D had about 40 percent lower incidence of dementia than non-users. The findings appear in a respected neurology journal and add to growing evidence on brain health and aging.

For Thailand, where the older population is expanding, these insights are timely. Vitamin D could play a role in a broader public health approach to cognitive well-being, especially as lifestyle shifts and air quality concerns influence health outcomes. Thai healthcare experts note that aging, combined with urban living and environmental factors, poses rising demands on the health system.

A new study spotlights nicotinamide riboside (NR), a form of vitamin B3, as a promising option to support brain health and slow Alzheimer’s progression. Researchers from the University of Delaware College of Health Sciences and the National Institute on Aging found that NR can cross the blood-brain barrier and may help preserve neurons and brain energy metabolism as people age.

Alzheimer’s disease remains a major health challenge worldwide, including Thailand, where an aging population increases demand for prevention and treatment strategies. Current therapies primarily address symptoms rather than the disease itself. The latest findings align with a broader interest in NAD+ precursors like NR as potential neuroprotective options because they help maintain cellular energy in the brain. Data from leading research institutions suggests NR could offer protective benefits against neurodegeneration.